LY2922470 is primarily utilized in the field of medical research, particularly in the study of metabolic disorders. It functions as a glucokinase activator, which plays a crucial role in regulating blood glucose levels. This makes it a valuable compound in the investigation of potential treatments for type 2 diabetes. By enhancing the activity of glucokinase, it helps in improving insulin secretion and glucose metabolism, which are critical factors in managing diabetes. Researchers are also exploring its potential in addressing other conditions related to glucose homeostasis. Its application in preclinical studies provides insights into the development of novel therapeutic agents targeting metabolic pathways.